Lu Peng: insider trades.
Lu Peng reported 13 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($4.7M), across 1 company.
- Transactions
- 13
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Lu Peng
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Pharvaris N.V. (PHVS) | Officer · President | 13 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-22 | Pharvaris N.V. | M | 45,308 | $2.59 | 110,261 | Form 4 |
| 2026-09-17 | Pharvaris N.V. | M | 100,000 | $2.59 | 164,953 | Form 4 |
| 2026-09-17 | Pharvaris N.V. | S | 100,000 | $35 | 64,953 | Form 4 |
| 2026-09-14 | Pharvaris N.V. | F | 117 | $38.02 | 64,953 | Form 4 |
| 2026-09-11 | Pharvaris N.V. | F | 109 | $37.51 | 65,070 | Form 4 |
| 2026-09-11 | Pharvaris N.V. | S | 15,000 | $40.13 | 65,179 | Form 4 |
| 2026-09-11 | Pharvaris N.V. | M | 15,000 | $2.59 | 80,179 | Form 4 |
| 2026-09-08 | Pharvaris N.V. | M | 15,000 | $2.59 | 80,179 | Form 4 |
| 2026-09-08 | Pharvaris N.V. | S | 15,000 | $40.68 | 65,179 | Form 4 |
| 2026-08-12 | Pharvaris N.V. | F | 117 | $34.42 | 65,179 | Form 4 |
| 2026-08-11 | Pharvaris N.V. | F | 109 | $34.84 | 65,296 | Form 4 |
| 2026-07-12 | Pharvaris N.V. | F | 117 | $35.07 | 65,405 | Form 4 |
| 2026-07-11 | Pharvaris N.V. | F | 109 | $35.07 | 65,522 | Form 4 |
Questions
What stock did Lu Peng buy or sell?
Lu Peng reported 13 non-derivative transactions on 6 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($4.7M), across 1 company.
Is Lu Peng the same person as other filers with this name?
This page covers SEC CIK 1972159 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/lu-peng-1972159.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.